Determining who foots the bill for America’s growing opioid epidemic may depend on how well the state of Oklahoma deploys a high-risk legal strategy next week against Johnson & Johnson and Teva Pharmaceutical Industries Ltd. At least 42 states and …
Source: Claims Journal